HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

Medicaid Unwinding Reverses Coverage Gains, Uninsured Rate Rises in 2024

KFF data show 1.3M more Americans uninsured in 2024 as Medicaid disenrollments outpaced new Marketplace sign-ups, reversing pandemic-era gains.

By RxInsider Editorial · Apr 17, 2026 · 352 words · via KFF Health News
Medicaid Unwinding Reverses Coverage Gains, Uninsured Rate Rises in 2024

Image: KFF Health News

New analysis from KFF Health News, published April 9, 2026, shows that the number of uninsured Americans under age 65 rose by more than 1.3 million in 2024 to reach 26.7 million. That marks the first uptick in the uninsured rate since 2019. The rate climbed from 9.5% to 9.8%, driven mainly by a drop in Medicaid coverage after the continuous enrollment policy ended in 2023. Nearly all states finished Medicaid eligibility redeterminations by the end of 2024, and millions lost coverage. Enrollment in ACA Marketplace plans did rise, but not enough to offset the Medicaid decline. KFF found that over 80% of the uninsured are in low-income families, about 85% live in households with at least one worker, and most reside in states that have not expanded Medicaid under the ACA.

The data show that post-pandemic Medicaid unwinding and changing policy are reshaping the U.S. coverage landscape in real time. The rollback of continuous enrollment and the upcoming expiration of enhanced Marketplace subsidies, triggered by the 2025 reconciliation law, are on track to drive further coverage erosion. The Congressional Budget Office projects that over 14 million additional people will be uninsured by 2034 if current policies hold. For payers and providers, that shift signals heavier uncompensated care loads and sicker patients in safety-net settings. On the financial side, PBM economics and provider reimbursement will be pulled toward greater noncommercial exposure as Medicaid declines faster than private coverage expands. A subtle but consequential rebalancing.

Viewed another way, the reversal looks like an early warning for state budgets and hospital margins through 2026 and beyond, especially in non-expansion states. With federal subsidies likely to wane, Marketplace affordability gaps are widening and may soon define the next policy flashpoint. Premium assistance and state-based subsidies are becoming contested ground. Investors should keep a close eye on how state coverage experiments interact with federal policy because those interactions will set the tone for payer enrollment and bad-debt risk across the health system. And honestly, after watching these cycles for years, this feels less like a one-year blip and more like the start of another slow unwind.

Tags
dataformat:briefingsynthesispolicyresearch
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Data
All Data →
HPV Vaccine Access: Coverage Success, Uptake Problem
Data
Despite full insurance coverage, HPV vaccination rates plateau, with racial disparities and post-pandemic decl…
Apr 17, 2026
Employer Coverage Remains the Backbone of U.S. Health Insurance
DataBriefing
KFF says about 165.6M people under 65 had employer-sponsored coverage in 2025, though access varies widely by …
Apr 17, 2026
RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
DataFierceBiotech ↗
Clinical site selection platform RyghtAI has launched a search engine designed to give drug developers and con…
Apr 17, 2026